Quantib ND

Quantib ND 2.0 is a medical imaging software that automates the segmentation and volumetric quantification of brain structures and white matter hyperintensities from MRI scans using an atlas-based methodology on the Quantib AI Node platform. It provides clinicians with quantitative data, visualizations, and longitudinal tracking to aid in the assessment and reporting of neurological conditions.

Quantib ND 2.0 is an advanced medical imaging processing software designed as an extension for the Quantib AI Node platform. Its primary purpose is the automatic labeling, visualization, and volumetric quantification of identifiable brain structures and white matter hyperintensities (WMH) derived from magnetic resonance (MR) images. The system processes 3D T1-weighted MR images for brain structure segmentation and requires an additional T2-weighted FLAIR MR image for WMH segmentation. It operates using a segmentation system based on multiple atlases, each comprising a 3D T1-weighted MR image and a corresponding label map that divides the MR image into distinct tissue segments. Quantib ND 2.0 provides quantitative information on both absolute and relative volumes of segmented regions and supports single time-point analysis as well as longitudinal analysis across two or more time-points. The outputs, including segmentations, visualizations, and volumetric measurements (which can be compared to reference centile data), are intended to offer complementary information to trained medical professionals, aiding them in the evaluation, assessment, and quantitative reporting of MR brain images. A key modification in Quantib ND 2.0 from its predicate (Quantib ND 1.5) is its integration with the Linux-based Quantib AI Node, transitioning from a Windows-based third-party platform, and adopting a server-client architecture accessible via a web browser. User interaction has been simplified; for instance, brain structure segmentation results are now directly added to reports as volumetric measures and overview images, with full segmentations exportable for detailed analysis. While the core algorithm design for segmentation remains consistent, the software architecture for integration has been updated. Performance validation compared automated segmentations to manual ones. For brain structures like brain tissue, CSF, ICV, hippocampus, and various lobes, Dice indices ranged from 0.78 (CSF) to 0.99 (Cerebellum), with absolute differences in relative volumes generally below 1.7 percentage points. For White Matter Hyperintensities, the average Dice overlap was 0.61 ± 0.13, and the absolute difference of relative volumes was 0.2 ± 0.2 percentage points, with WMH segmentation requiring user review and potential editing before validation. Reports and segmentations are automatically exported to a configured DICOM node.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the algorithm's performance (e.g., Dice scores) for brain structure and WMH segmentation translate to clinical decision-making in specific neurological conditions?; What are the limitations of the atlas-based segmentation, especially in brains with significant atrophy, novel lesions, or anatomical variants not well-represented in the atlas dataset?; How robust is the longitudinal analysis to variations in MRI acquisition parameters and inter-scanner differences over time for the same patient?; What specific "reference centile data" is used for comparison of volumetric measurements, and how was this normative database established and validated for diverse populations?; Given the Dice index of 0.61 for White Matter Hyperintensities, what is the anticipated clinical impact of relying on user review and editing for these segmentations versus further algorithmic improvement?